— Know what they know.
Not Investment Advice
Also trades as: CAN.AX (ASX) · $vol 0M

CNGGF OTC

Cann Group Limited
1W: +41.2% 1M: -16.9% 3M: -16.9% YTD: -53.3% 1Y: -43.5% 3Y: -96.5% 5Y: -98.7%
$0.00
-0.00 (-20.42%)
 
Weekly Expected Move ±28.8%
$0 $0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $4.7M mcap · 1.43B float · 0.0003% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$9M -35.5% ▼
5Y CAGR: -0.0%
Gross Profit
-$8M -256.2% ▼
Operating Income
-$12M -34.2% ▼
Net Income
$20M +190.7% ▲
EPS (Diluted)
$0.02 +139.5% ▲
EBITDA
-$6M +31.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$11M$21M$15M$13M$9M
YoY Growth+31.2%+83.6%-25.5%-13.8%-35.5%
Cost of Revenue$0$15M$9M$8M$17M
Gross Profit$11M$6M$6M$5M-$8M
Gross Margin100.0%26.8%40.2%38.9%-94.1%
R&D Expenses$3M$4M$755K$781K$41K
SG&A Expenses$28M$33M$30M$13M$4M
Operating Expenses$31M$23M$20M$14M$4M
Operating Income-$19M-$18M-$13M-$9M-$12M
Operating Margin-173.1%-86.1%-87.7%-67.5%-140.3%
Interest Expense$2M$3M$7M$6M$5M
Income Before Tax-$26M-$34M-$51M-$22M$20M
Tax Expense$0$0$0$0-$744K
Net Income-$26M-$34M-$51M-$22M$20M
Net Margin-235.5%-163.8%-333.3%-168.6%237.1%
EPS (Diluted)$-0.08$-0.09$-0.11$-0.04$0.02
EBITDA-$20M-$19M-$33M-$9M-$6M
Shares Outstanding338M372M454M528M1.22B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms